24 November 2020
Dentons advises ATAI Life Sciences on its $125 million Series C financing
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Thomas Schubert Lead | Dentons | Partner | Corporate | Berlin |
| Kristina Beirne | Dentons | Partner | Corporate | New York |
| Oliver Dreher | Dentons | Partner | Banking and Finance | Frankfurt |
| Dr. Robert Weber | Dentons | Partner | Corporate | Frankfurt |
| Julia Sieber | Dentons | Counsel | Corporate | Frankfurt |
| David Hauser | Dentons | Associate | Corporate | Frankfurt |
| Dimitrios Andreadis | Dentons | Senior associate | Corporate | Munich |
Stated terms
- Stated value
- USD 125m ($125 million)
- What the figure measures
- Issue size
- Client
- ATAI Life SciencesIssuer
- Counterparties
- Apeiron Investment Group (Investor)
Peter Thiel (Investor)
Catalio Capital Management (Investor)
Future Ventures (Investor)
Galaxy Investment Partners (Investor)
Falcon Edge Capital (Investor)
Pura Vida Pro (Investor)